
|Videos|October 15, 2021
Dr. Tagawa on treatment patterns and survival in mCSPC
Author(s)Urology Times staff
Advertisement
Scott T. Tagawa, MD, discusses the background and results of the study, “Treatment patterns and overall survival in metastatic castration-sensitive prostate cancer from 2006 to 2019,” which was presented during the 2021 ESMO Congress.
Tagawa is a professor of Medicine and Urology at Weill Cornell Medicine, and an attending physician at NewYork-Presbyterian/Weill Cornell Medical Center.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
ARASEC: Clinical Implications and the Role of Multidisciplinary Care
2
NCCN recommends ctDNA-MRD testing to guide adjuvant treatment post-cystectomy
3
Lymph Node Dissection Following Systemic Therapy in MIBC
4
European Commission approves perioperative EV/pembrolizumab for cisplatin-ineligible MIBC
5













